Galectin-3 binds to lubricin and reinforces the lubricating boundary layer of articular cartilage

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Reesink, Heidi L ^a   Bonnevie, Edward D ^b   Liu, Sherry ^a   Shurer, Carolyn R ^b   Hollander, Michael J ^b   Bonassar, Lawrence J ^b   Nixon, Alan J ^a  

^a Cornell University ^*  (United States)

^b School of Operations Research and Industrial Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; GLYCOPROTEIN; LUBRICIN; PROTEIN BINDING;

ANIMAL; ARTICULAR CARTILAGE; BOVINE; GLYCOBIOLOGY; HORSE; HUMAN; KINETICS; LUBRICATION; METABOLISM; PHENOTYPE;

ANIMALS; CARTILAGE, ARTICULAR; CATTLE; GALECTIN 3; GLYCOMICS; GLYCOPROTEINS; HORSES; HUMANS; KINETICS; LUBRICATION; PHENOTYPE; PROTEIN BINDING;

EID: 84971014145     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25463     Document Type: Article

References (60)

1. Cui, Z., Xu, C., Li, X., Song, J. and Yu, B. Treatment with recombinant lubricin attenuates osteoarthritis by positive feedback loop between articular cartilage and subchondral bone in ovariectomized rats. Bone 74, 37-47 (2015).
2. Ruan, M. Z. C. et al. Proteoglycan 4 expression protects against the development of osteoarthritis. Sci. Transl. Med. 5, 176ra34 (2013).
3. Jay, G. D. et al. Prevention of Cartilage Degeneration and Restoration of Chondroprotection by Lubricin Tribosupplementation in the Rat Following ACL Transection. Arthritis Rheum. 62, 2382-2391 (2010).
4. Flannery, C. R. et al. Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin. Arthritis Rheum. 60, 840-7 (2009).
5. Jay, G. D. et al. Prevention of cartilage degeneration and gait asymmetry by lubricin tribosupplementation in the rat following anterior cruciate ligament transection. Arthritis Rheum. 64, 1162-71 (2012).
6. Bahabri, S. et al. The camptodactyly-arthropathy-coxa vara-pericarditis syndrome: clinical features and genetic mapping to human chromosome 1. Arthritis Rheum. 41, 730-735 (1998).
7. Swann, D. A., Silver, F. H., Slayter, H. S., Stafford, W. and Shore, E. The molecular structure and lubricating activity of lubricin isolated from bovine and human synovial fluids. Biochem. J. 225, 195-201 (1985).
8. Jay, G. D., Britt, D. E. and Cha, C.-J. Lubricin Is a Product of MSF Gene Expression by Human Synovial Fibroblasts. J. Rheumatol. 27, 594-600 (2000).
9. Swann, D. A., Sotman, S., Dixon, M. and Brooks, C. The isolation and partial characterization of the major glycoprotein (LGP-I) from the articular lubricating fraction from bovine synovial fluid. Biochem. J. 161, 473-85 (1977).
10. Ali, L. et al. The O-glycomap of lubricin, a novel mucin responsible for joint lubrication, identified by site-specific glycopeptide analysis. Mol. Cell. proteomics doi: 10.1074/mcp.M114.040865 (2014).
11. Gleghorn, J. P., Jones, A. R. C., Flannery, C. R. and Bonassar, L. J. Boundary mode lubrication of articular cartilage by recombinant human lubricin. J. Orthop. Res. 27, 771-7 (2009).
12. Jay, G. D., Tantravahi, U., Britt, D. E., Barrach, H. J. and Cha, C. J. Homology of lubricin and superficial zone protein (SZP): Products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25. J. Orthop. Res. 19, 677-687 (2001).
13. Jay, G. D., Harris, D. a and Cha, C. J. Boundary lubrication by lubricin is mediated by O-linked beta(1-3)Gal-GalNAc oligosaccharides. Glycoconj. J. 18, 807-15 (2001).
14. Jay, G. D., Lane, B. P. and Sokoloff, L. Characterization of a bovine synovial fluid lubricating factor III. The interaction with hyaluronic acid. Connect. Tissue Res. 28, 245-255 (1992).
15. Benz, M., Chen, N., Jay, G. and Israelachvili, J. Static forces, structure and flow properties of complex fluids in highly confined geometries. Ann. Biomed. Eng. 33, 39-51 (2005).
16. Dube, D. H. and Bertozzi, C. R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4, 477-88 (2005).
17. Swann, D. A., Bloch, K. J., Swindell, D. and Shore, E. The lubricating activity of human synovial fluids. Arthritis Rheum. 27, 552-6 (1984).
18. Estrella, R. P., Whitelock, J. M., Packer, N. H. and Karlsson, N. G. The glycosylation of human synovial lubricin: implications for its role in inflammation. Biochem. J. 429, 359-67 (2010).
19. Svala, E. et al. Characterisation of lubricin in synovial fluid from horses with osteoarthritis. Equine Vet. J. doi: 10.1111/evj.12521 (2015).
20. Jay, G. D. Characterization of a bovine synovial fluid lubricating fator.I. Chemical, surface activity and lubricating properties. Connect Tissue Res. 28, 71-88 (1992).
21. Teeple, E. et al. Coefficients of Friction, Lubricin, and Cartilage Damage in the Anterior Cruciate Ligament-Deficient Guinea Pig Knee. 26, 231-237 (2008).
22. Elsaid, K. A., Machan, J. T., Waller, K., Fleming, B. C. and Jay, G. D. The impact of anterior cruciate ligament injury on lubricin metabolism and the effect of inhibiting tumor necrosis factor alpha on chondroprotection in an animal model. Arthritis Rheum. 60, 2997-3006 (2009).
23. Nagae, M. and Yamaguchi, Y. Sugar recognition and protein - protein interaction of mammalian lectins conferring diverse functions. Curr. Opin. Struct. Biol. 34, 108-115 (2015).
24. Brewer, C. F., Miceli, M. C. and Baum, L. G. Clusters, bundles, arrays and lattices: Novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr. Opin. Struct. Biol. 12, 616-623 (2002).
25. van Kooyk, Y. and Rabinovich, G. A. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9, 593-601 (2008).
26. Toegel, S. et al. Human osteoarthritic knee cartilage: fingerprinting of adhesion/growth-regulatory galectins in vitro and in situ indicates differential upregulation in severe degeneration. Histochem. Cell Biol. 142, 373-88 (2014).
27. Ohshima, S. et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 48, 2788-95 (2003).
28. Jin, C. et al. Human synovial lubricin expresses sialyl Lewis x determinant and has L-selectin ligand activity. J. Biol. Chem. 287, 35922-33 (2012).
29. Earl, L. A., Bi, S. and Baum, L. G. N- and O-Glycans modulate galectin-1 binding, CD45 signaling, and T cell death. J. Biol. Chem. 285, 2232-2244 (2010).
30. Krzeminski, M. et al. Human galectin-3 (Mac-2 antigen): Defining molecular switches of affinity to natural glycoproteins, structural and dynamic aspects of glycan binding by flexible ligand docking and putative regulatory sequences in the proximal promoter region. Biochim. Biophys. Acta - Gen. Subj. 1810, 150-161 (2011).
31. Young, A. A. et al. Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis. Arthritis Res. Ther. 8, R41 (2006).
32. Elsaid, K. A., Jay, G. D. and Chichester, C. O. Reduced expression and proteolytic susceptibility of lubricin/superficial zone protein may explain early elevation in the coefficient of friction in the joints of rats with antigen-induced arthritis. Arthritis Rheum. 56, 108-16 (2007).
33. Jones, A. R. C. et al. Binding and Localization of Recombinant Lubricin to Articular Cartilage Surfaces. J. Orthop. Res. 12, 10-12 (2007).
34. Dam, T. K. et al. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 44, 12564-71 (2005).
35. Hirabayashi, J. et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta 1572, 232-54 (2002).
36. Gleghorn, J. P., Jones, a R. C., Flannery, C. R. and Bonassar, L. J. Boundary mode frictional properties of engineered cartilaginous tissues. Eur. Cell. Mater. 14, 20-8, discussion 28-9 (2007).
37. Ahmad, N. et al. Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Crosslinked Complexes. J. Biol. Chem. 279, 10841-10847 (2004).
38. Demetriou, M., Granovsky, M., Quaggin, S. and Dennis, J. W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733-739 (2001).
39. Mirandola, L. et al. Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma. PLoS One 6, e21811 (2011).
40. Elola, M. T., Wolfenstein-Todel, C., Troncoso, M. F. and Vasta, G. R. and Rabinovich, G. a. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell. Mol. Life Sci. 64, 1679-700 (2007).
41. Rabinovich, G. A., Toscano, M. A., Jackson, S. S. and Vasta, G. R. Functions of cell surface galectin-glycoprotein lattices. Curr. Opin. Struct. Biol. 17, 513-20 (2007).
42. Harjacek, M. et al. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis. J. Rheumatol. 28, 1914-1922 (2001).
43. Ezzat, M. H. M., El-Gammasy, T. M. A., Shaheen, K. Y. A. and Osman, A. O. Y. Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression. Int. J. Rheum. Dis. 14, 345-52 (2011).
44. Xibillé-Friedmann, D., Bustos Rivera-Bahena, C., Rojas-Serrano, J., Burgos-Vargas, R. and Montiel-Hernández, J.-L. A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis. Scand. J. Rheumatol. 42, 102-7 (2013).
45. Swann, D. A. and Mintz, G. The isolation and properties of a second glycoprotein (LGP-II) from the articular lubricating fraction from bovine synovial fluid. Biochem. J. 179, 465-71 (1979).
46. Hosaka, S., Shah, M. R., Pope, R. M. and Koch, A. E. Soluble forms of P-selectin and intercellular adhesion molecule-3 in synovial fluids. Clin. Immunol. Immunopathol. 78, 276-82 (1996).
47. Alturfan, a A., Eralp, L. and Emekli, N. Investigation of inflammatory and hemostatic parameters in female patients undergoing total knee arthroplasty surgery. Inflammation 31, 414-21 (2008).
48. Janelle-Montcalm, A. et al. Extracellular localization of galectin-3 has a deleterious role in joint tissues. Arthritis Res. Ther. 9, R20 (2007).
49. Forsman, H. et al. Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis. Arthritis Rheum. 63, 445-54 (2011).
50. Li, X., Zhao, Q.-Y. and Yuan, F.-L. Galectin 3 as a novel therapeutic target in rheumatoid arthritis: comment on the article by Forsman et al. Arthritis Rheum. 63, 3179-80. (2011).
51. Guévremont, M. et al. Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3. Ann. Rheum. Dis. 63, 636-43 (2004).
52. Toegel, S. et al. Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein. Arthritis Res. Ther. 15, R147 (2013).
53. Arthur, C. M., Baruffi, M. D., Cummings, R. D. and Stowell, S. R. Evolving mechanistic insights into galectin functions. Methods Mol. Biol. 1207, 1-35 (2015).
54. Boileau, C. et al. Intracellular localisation of galectin-3 has a protective role in chondrocyte survival. Annals of the rheumatic diseases 67, 175-81 (2008).
55. Reboul, P., Martel-Pelletier, J. and Pelletier, J.-P. Galectin-3 in osteoarthritis: when the fountain of youth doesnt deliver its promises. Curr. Opin. Rheumatol. 16, 595-8 (2004).
56. Kumar, P. et al. Role of uppermost superficial surface layer of articular cartilage in the lubrication mechanism of joints. J. Anat. 199, 241-250 (2001).
57. Das, S. et al. Synergistic interactions between grafted hyaluronic acid and lubricin provide enhanced wear protection and lubrication. Biomacromolecules 14, 1669-1677 (2013).
58. Bian, C.-F., Zhang, Y., Sun, H., Li, D.-F. and Wang, D.-C. Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen. PLoS One 6, e25007 (2011).
59. Teeple, E. et al. The Effects of Supplemental Intra-Articular Lubricin and Hyaluronic Acid on the Progression of Post-Traumatic Arthritis in the Anterior Cruciate Ligament Deficient Rat Knee. Am. J. Sports Med. 39, 164-172 (2011).
60. Pace, K. E., Hahn, H. P. and Baum, L. G. Preparation of recombinant human galectin-1 and use in T-cell death assays. Methods Enzymol. 363, 499-518 (2003).